Facebook Twitter Linkedin

Join us  |  Contact  | Giving

Tel: 972-2-6758725
Search
  • Home
  • The Lautenberg Center
    • About the Center
    • Lab in the Spotlight
    • Donors and Friends of the Center
    • Senator Lautenberg
    • Rabbi Shai Shacknai Award
    • James Sivarsten Award
    • Annual Retreats
    • Events Gallery
    • Annual Progress Report
  • People
    • Faculty
    • Emeritus Faculty
    • Management & Administrative Staff
    • Hall of Fame
    • Alumni Members and Students
  • Seminars
  • Facilities
Menu
  • Home
  • The Lautenberg Center
    • About the Center
    • Lab in the Spotlight
    • Donors and Friends of the Center
    • Senator Lautenberg
    • Rabbi Shai Shacknai Award
    • James Sivarsten Award
    • Annual Retreats
    • Events Gallery
    • Annual Progress Report
  • People
    • Faculty
    • Emeritus Faculty
    • Management & Administrative Staff
    • Hall of Fame
    • Alumni Members and Students
  • Seminars
  • Facilities

Prof. Eli Kedar

Email:    elike@ekmd.huji.ac.il

Research interests
Lab members
Research projects
Publications
major collaborations
Social activities
Research interests
Lab members
Research projects
Publications

 

Antigenic relationships between cell membranes of normal and SV40 transformed hamster kidney cells.

Kedar E, Wiener M, Goldblum N, Sulitzeanu D.

Isr J Med Sci. 1971 Jan;7(1):132-43.

Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.

Kedar E, Otiz de Landazuri M, Fahey JL.

J Immunol. 1974 Jan;112(1):26-36.

Cellular immunoadsorbents. An improved technique for specific depletion of cytotoxic (T) lymphoid cells.

Kedar E, Ortiz de Landazuri M, Bonavida B, Fahey JL.

J Immunol Methods. 1974 May;5(1):97-102

In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes.

Kedar E, Unger E, Schwartzbach M.

J Immunol Methods. 1976;13(1):1-19.

Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).

Kedar E, Ikejiri BL, Gorelik E, Herbermann RB.

Cancer Immunol Immunother. 1982;13(1):14-23.

The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.

Kedar E, Weiss DW.

Adv Cancer Res. 1983;38:171-287. Review.

Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.

Kedar E, Chriqui-Zeira E, Kyriazis AP.

J Biol Response Mod. 1984 Oct;3(5):517-26.

Therapy of advanced solid tumors in mice using chemotherapy in combination with interleukin-2 with and without lymphokine-activated killer cells.

Kedar E, Ben-Aziz R, Shiloni E.

Isr J Med Sci. 1988 Sep-Oct;24(9-10):494-504.

Cancer immunotherapy: are the results discouraging? Can they be improved?

Kedar E, Klein E.

Adv Cancer Res. 1992;59:245-322. Review

Chemo-immunotherapy of murine solid tumors: enhanced therapeutic effects by interleukin-2 combined with interferon alpha and the role of specific T cells.

Kedar E, Rutkowski Y, Leshem B.

Cancer Immunol Immunother. 1992;35(1):63-8.

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with dacarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response.

Isacson R, Kedar E, Barak V, Gazit Z, Yurim O, Kalichman I, Ben-Bassat H, Biran S, Schlesinger M, Franks CR, et al.

Immunol Lett. 1992 Jul;33(2):127-34.

Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice.

Kedar E, Braun E, Rutkowski Y, Emanuel N, Barenholz Y.

J Immunother Emphasis Tumor Immunol. 1994 Aug;16(2):115-24.

Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice.

Emanuel N, Kedar E, Bolotin EM, Smorodinsky NI, Barenholz Y.

Pharm Res. 1996 Jun;13(6):861-8.

Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2.

Cabanes A, Even-Chen S, Zimberoff J, Barenholz Y, Kedar E, Gabizon A.

Clin Cancer Res. 1999 Mar;5(3):687-93.

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice.

Babai I, Samira S, Barenholz Y, Zakay-Rones Z, Kedar E.

Vaccine. 1999 Mar 5;17(9-10):1223-38.

Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines.

van Slooten ML, Hayon I, Babai I, Zakay-Rones Z, Wagner E, Storm G, Kedar E.

Biochim Biophys Acta. 2001 Mar 30;1531(1-2):99-110.

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M, Kedar E.

Vaccine. 2001 Nov 12;20(3-4):505-15.

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.

Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Barenholz Y, Kedar E.

J Med Virol. 2003 Apr;69(4):560-7.

Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents.

Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Glück R, Zurbriggen R, Kedar E.

Vaccine. 2003 Jul 4;21(23):3169-78.

A new intranasal influenza vaccine based on a novel polycationic lipid–ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D, Goldwaser I, Barenholz Y, Kedar E.

Vaccine. 2006 May 1;24(18):3990-4006.

Adjuvanted influenza vaccines.

Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y.

Expert Rev Vaccines. 2013 Sep;12(9):1095-108.

 

major collaborations
Social activities
  • Faculty
  • Emeritus Faculty
  • Management and Administrative Staff
  • Hall of Fame
  • Alumni Members and Students

The Lautenberg center for immunology and cancer research

Israel-Canada Medical Research Institute Faculty of Medicine,
The Hebrew University

POB 12272, Jerusalem 91120, Israel

Tel: 972-2-6757725

Fax: 972-2-6430834

  • Home
  • The Lautenberg Center
  • People
  • Facilities
  • contact us
Menu
  • Home
  • The Lautenberg Center
  • People
  • Facilities
  • contact us
Scroll to top
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset